34 minutes | Oct 12, 2020

How do you launch a therapy for an ultra-rare disease?

In this special bonus episode, we deep dive into rare disease and reveal not one but two perspectives from specialists in this area. First Leena Delal, Vice President, US Brand Lead at Alnylam tells the story behind ONPATTRO – a therapy that astounded doctors and patients with its ability to reverse the debilitating nerve damage caused by ultra-rare disease hATTR amyloidosis. Then, our Creative Director Kristin Morris, reveals what she learned in 11 years working solely in rare disease. She covers the changing landscape, how COVID-19 is impacting the patients, and her tips for ensuring authenticity in a virtual world.
Play Next